avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD4
|
ENSG00000141646.9 | SMAD family member 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD4 | hg19_v2_chr18_+_48556470_48556640 | -0.83 | 7.4e-06 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
1.0 | 3.0 | GO:1904300 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.9 | 6.2 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.8 | 5.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.7 | 4.9 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 2.0 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.7 | 4.7 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.6 | 1.9 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.6 | 2.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.6 | 1.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.6 | 1.7 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.5 | 1.6 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.5 | 3.2 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.5 | 1.6 | GO:0001300 | chronological cell aging(GO:0001300) |
0.5 | 1.9 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.5 | 3.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.5 | 0.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 2.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.4 | 1.2 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.4 | 2.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.4 | 1.2 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.3 | 1.0 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.3 | 1.0 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.3 | 1.0 | GO:0031247 | actin rod assembly(GO:0031247) |
0.3 | 2.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.3 | 3.7 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.3 | 0.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 2.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.3 | 0.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 1.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 0.8 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 0.8 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.3 | 0.5 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 1.0 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.3 | 1.0 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.3 | 7.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 2.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 1.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 0.7 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 0.7 | GO:1900082 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.2 | 1.7 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.2 | 1.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 2.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 1.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.9 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.2 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.9 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.2 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.1 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 0.6 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.2 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.2 | 0.6 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.2 | 0.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 3.6 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 0.8 | GO:0002884 | negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
0.2 | 1.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 1.1 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 3.3 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.8 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 1.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 1.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 0.5 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.2 | 1.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 0.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.2 | 2.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.5 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.1 | 0.6 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.9 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.6 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 3.4 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.6 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 2.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 1.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.4 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.1 | 0.1 | GO:1901205 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.1 | 1.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.1 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.5 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.1 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.7 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 0.4 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 0.4 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 1.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 1.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.3 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 1.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.3 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.7 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 1.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.8 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.6 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 3.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 2.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 1.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.5 | GO:0090341 | regulation of secretion of lysosomal enzymes(GO:0090182) negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 4.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.5 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.1 | 0.7 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.4 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.3 | GO:1990637 | response to prolactin(GO:1990637) regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.7 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.1 | 0.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.5 | GO:0006311 | meiotic gene conversion(GO:0006311) male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.2 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.5 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.3 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.1 | 0.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.9 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.1 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
0.1 | 0.8 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 1.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 1.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 1.4 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.1 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.6 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 1.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.1 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 2.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.1 | 0.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.1 | 1.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0035246 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.3 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.1 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.1 | 0.2 | GO:0048003 | synaptic vesicle recycling via endosome(GO:0036466) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.2 | GO:0048850 | cardiac right atrium morphogenesis(GO:0003213) chemoattraction of serotonergic neuron axon(GO:0036517) hypophysis morphogenesis(GO:0048850) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
0.1 | 0.9 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
0.1 | 1.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.2 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 | 0.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 0.6 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.0 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 1.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.0 | 0.7 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.0 | 1.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 1.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.0 | 0.5 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.0 | 0.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.0 | 0.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.7 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0061205 | alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
0.0 | 0.5 | GO:0042089 | cytokine biosynthetic process(GO:0042089) cytokine metabolic process(GO:0042107) |
0.0 | 1.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 1.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) response to xenobiotic stimulus(GO:0009410) cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 0.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.0 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.0 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.2 | GO:0050968 | detection of temperature stimulus involved in thermoception(GO:0050960) detection of chemical stimulus involved in sensory perception of pain(GO:0050968) response to capsazepine(GO:1901594) |
0.0 | 0.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 1.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.2 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.2 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 2.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.0 | 0.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 1.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 2.5 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.0 | 0.5 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.5 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.0 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 1.3 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.8 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.0 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.0 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 0.4 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.0 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 1.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.2 | GO:1901295 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) Clara cell differentiation(GO:0060486) arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.6 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.7 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 1.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.2 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.0 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.0 | 0.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.7 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 2.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 1.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.0 | 0.2 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.1 | GO:0060126 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) somatotropin secreting cell differentiation(GO:0060126) prolactin secreting cell differentiation(GO:0060127) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.0 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.1 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.4 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0002415 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.0 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.1 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.0 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) negative regulation of mast cell degranulation(GO:0043305) |
0.0 | 0.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.0 | 0.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 0.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0032900 | negative regulation of neurotrophin production(GO:0032900) |
0.0 | 4.6 | GO:0043542 | endothelial cell migration(GO:0043542) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.3 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 1.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.2 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.0 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.4 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.0 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.2 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.3 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.5 | 1.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.5 | 2.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 5.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 2.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 1.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 1.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 6.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 6.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 2.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 4.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 1.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 6.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 0.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.8 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 1.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 7.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 2.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 1.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.0 | 1.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.1 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.0 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.0 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 5.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 1.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 2.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 3.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 3.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 4.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.0 | 3.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.8 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 3.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 2.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 1.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.1 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 1.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.7 | GO:0016363 | nuclear matrix(GO:0016363) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 8.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 2.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.6 | 1.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.5 | 1.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.5 | 3.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.4 | 1.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.4 | 1.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.4 | 1.1 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.4 | 2.6 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.4 | 1.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 1.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 2.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.3 | 5.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.9 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.3 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 1.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.2 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.2 | 0.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 0.7 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 0.7 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.2 | 3.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.2 | 1.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.6 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.2 | 3.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 1.6 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.8 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 0.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 3.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 4.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 2.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 2.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 0.4 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 2.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 5.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.4 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 2.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 1.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 5.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.9 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.1 | 0.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 1.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.0 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 2.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 1.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 1.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.0 | 0.7 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 1.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 1.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0086078 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.0 | 0.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 6.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 1.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.0 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0019959 | interleukin-8 receptor activity(GO:0004918) interleukin-8 binding(GO:0019959) |
0.0 | 0.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.6 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 1.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.8 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.6 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 2.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 3.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.0 | 0.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 1.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 3.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.6 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 1.2 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 4.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 1.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 4.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 1.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 5.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 4.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 11.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 6.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 3.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 4.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 3.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 4.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 3.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 5.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 2.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 4.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 2.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 1.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 4.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 1.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |